Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Clinical trial NCT00003517 · WITHDRAWN

Trial details

NCT number: NCT00003517
Sponsor: Burzynski Research Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Stage III Prostate Cancer Stage IV Prostate Cancer Recurrent Prostate Cancer

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.